Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of ...

View Xeris Biopharma Holdings, Inc. XERS stock quote prices, financial information, real-time forecasts, and company news from CNN.

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative ...

Earlier in 2026, Xeris Biopharma reported a record quarter of revenue growth and profitability for Q4 2025 and issued 2026 guidance targeting over 30% adjusted EBITDA growth and US$375 million to ...

Xeris Biopharma has not yet achieved cash flow breakeven and may no longer be a "Top Idea" in the Compounding Healthcare Investing Group. Xeris has three approved products and a strong pipeline, with ...

Xeris Biopharma Holdings (NASDAQ:XERS) is set to give its latest quarterly earnings report on Monday, 2026-03-02. Here's what investors need to know before the announcement. Analysts estimate that ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

A competitor's setback was Xeris Biopharma's (NASDAQ: XERS) gain on Hump Day. On news that a potential commercial threat to one of its three commercialized drugs had been neutralized (at least for now ...

We recently published a list of 11 Unstoppable Growth Stocks to Invest in Now. In this article, we are going to take a look at where Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) stands against other ...

Xeris Biopharma (NASDAQ:XERS) stock fell ~10% on Wednesday despite Q4 results beating estimates. Net loss narrowed to -$12.93M, compared to -$50.79M in Q4 2021. Total revenue grew +54.6% to $33.14.

Tel Aviv, Israel, Xeris today announced a major breakthrough in AI Agentic cybersecurity with its Patent Pending Super AI Agent technology, purpose built to secure the rapidly expanding world of ...

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative ...